Asymchem Laboratories (Tianjin) stock: fair value
002821.SZThe fair value of Asymchem Laboratories (Tianjin) under our model is $11.91, the price is 92% above.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $8.50 and expensive above $19.84 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $1.34 (cash-flow model) and $22.47 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.6%. At 9.6% the fair value would be $11.81, at 7.6% it would be $12.03.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (45.8).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 2.3%. Discounted at 8.6% (government bond yield 2.3% plus beta 1.22 times a risk premium of 5.1%); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $1.34 per share: free cash flow for the next ten years, each year discounted to today at 8.6%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 8.6%) |
|---|---|---|---|---|
| 2026 | $29.96M | extrapolated at 3.2% | 0.9209 | $27.59M |
| 2027 | $30.84M | extrapolated at 2.9% | 0.8480 | $26.15M |
| 2028 | $31.68M | extrapolated at 2.7% | 0.7809 | $24.74M |
| 2029 | $32.51M | extrapolated at 2.6% | 0.7191 | $23.38M |
| 2030 | $33.33M | extrapolated at 2.5% | 0.6622 | $22.07M |
| 2031 | $34.15M | extrapolated at 2.5% | 0.6098 | $20.82M |
| 2032 | $34.97M | extrapolated at 2.4% | 0.5616 | $19.64M |
| 2033 | $35.81M | extrapolated at 2.4% | 0.5171 | $18.52M |
| 2034 | $36.65M | extrapolated at 2.4% | 0.4762 | $17.45M |
| 2035 | $37.51M | extrapolated at 2.4% | 0.4385 | $16.45M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $216.82M |
| Terminal value: cash flow 2035 × (1 + 2.3%) / (8.6% − 2.3%) | $610.87M |
| Present value of terminal value (× 0.4385) | $267.88M |
| Equity value (sum plus present value of terminal value) | $484.69M |
| Shares (diluted) | 361.95M |
| Value per share (equity value divided by shares) | $1.34 |
| Earnings per share, last twelve months | $0.49 |
| × 45.8 (industry P/E) | $22.47 |
| Fair value (average of both parts) | $11.91 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 13 Dec 2024)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.